Teleflex Inc. (TFX) News

Teleflex Inc. (TFX): $200.95

1.14 (-0.56%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter TFX News Items

TFX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

TFX News Highlights

  • TFX's 30 day story count now stands at 6.
  • Over the past 21 days, the trend for TFX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about TFX are DEC, PRE and ST.

Latest TFX News From Around the Web

Below are the latest news stories about TELEFLEX INC that investors may wish to consider to help them evaluate TFX as an investment opportunity.

Has Teleflex Incorporated's (NYSE:TFX) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Most readers would already be aware that Teleflex's (NYSE:TFX) stock increased significantly by 28% over the past three...

Yahoo | December 26, 2023

Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference

WAYNE, Pa., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 9, 2024, at 3:00 p.m. (PT). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex

Yahoo | December 26, 2023

These 2 MedTech Stocks Look Too Cheap to Ignore, Says Morgan Stanley

Since early this century, the high-tech sector has picked up headlines and accolades – and rightly so. Our world is evolving into a technology-driven landscape, with tech making significant contributions to diverse fields such as finance, communications, and aerospace. Yet, it’s worth noting that the medical field has also been influenced by tech, even though its impact often receives less recognition in the headlines. But less publicity hasn’t meant fewer investment opportunities, and investmen

Yahoo | December 11, 2023

Why Is Waters (WAT) Up 13.2% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2023

Teleflex (TFX) Signs Peripheral Access Purchasing Deal With PINC

Teleflex (TFX) secures the Peripheral Access purchasing agreement with Premier, Inc.

Yahoo | December 6, 2023

Teleflex Awarded Peripheral Access Agreement with Premier, Inc.

WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Peripheral Access products. Premier has awarded Teleflex a national multi-source agreement for

Yahoo | December 5, 2023

Returns On Capital At Teleflex (NYSE:TFX) Have Stalled

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Yahoo | December 3, 2023

Here's Why You Should Retain Teleflex (TFX) Stock for Now

Investors remain optimistic about Teleflex (TFX) on the strength of the Vascular and Interventional businesses.

Yahoo | November 28, 2023

Teleflex (TFX) Enrolls First Patient in ACCESS-MANTA Registry

Teleflex's (TFX) ACCESS-MANTA Registry is likely to examine the contemporary on-label use of the MANTA VCD.

Yahoo | November 22, 2023

Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry

Registry Intends to Examine Contemporary On-Label Use of the MANTA™ Vascular Closure Device Including Appropriate Patient Selection and Proper Vascular AccessWAYNE, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical registry that is intended to examine and collect data on outcomes of contemporary on-label use of the MANTA™ Vascular Closure Device (VCD) in standard

Yahoo | November 16, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!